AMGAD M. RABIE^*

BIOCELL, Vol.47, No.10, pp. 2133-2139, 2023, DOI:10.32604/biocell.2023.030057

Abstract Despite the global decline in the severity of the coronavirus disease 2019 (COVID-19) cases, the disease still represents a major concern to the relevant scientific and medical communities. The primary concern of drug scientists, virologists, and other concerned specialists in this respect is to find ready-to-use suitable and potent anticoronaviral therapies that are broadly effective against the different species/strains of the coronaviruses in general, not only against the current and previous coronaviruses (e.g., the recently-appeared severe acute respiratory syndrome coronavirus 2 “SARS-CoV-2”), i.e., effective antiviral agents for treatment and/or prophylaxis of any coronaviral infections, including those of the coming ones… More > Graphic Abstract

Ahmad M. Al-Omari^1,*, Shefa M. Tawalbeh¹, Yazan H. Akkam², Mohammad Al-Tawalbeh³, Shima’a Younis¹, Abdullah A. Mustafa⁴, Jonathan Arnold⁵

CMC-Computers, Materials & Continua, Vol.75, No.2, pp. 4155-4173, 2023, DOI:10.32604/cmc.2023.036956

Abstract There are quintillions of data on deoxyribonucleic acid (DNA) and protein in publicly accessible data banks, and that number is expanding at an exponential rate. Many scientific fields, such as bioinformatics and drug discovery, rely on such data; nevertheless, gathering and extracting data from these resources is a tough undertaking. This data should go through several processes, including mining, data processing, analysis, and classification. This study proposes software that extracts data from big data repositories automatically and with the particular ability to repeat data extraction phases as many times as needed without human intervention. This software simulates the extraction of… More >

SUCHITRA NISHAL¹, VIKAS JHAWAT^1,*, SUMEET GUPTA², PARMITA PHAUGAT¹

Oncology Research, Vol.30, No.5, pp. 221-230, 2022, DOI:10.32604/or.2022.027549

Abstract Kinase inhibitors are a significant and continuously developing division of target therapeutics. The drug discovery and improvement efforts have examined numerous attempts to target the signaling pathway of kinases. The Kinase inhibitors have been heralded as a game-changer in cancer treatment. For developing kinase inhibitors as a treatment for various non-malignant disorders like auto-immune diseases, is currently undergoing extensive research. It may be beneficial to investigate whether cell-specific kinase inhibitor administration enhances therapeutic efficacy and decreases adverse effects. The goal of the current review is to gain insight into the role of kinase inhibitors in facilitating effective target drug delivery… More >